$21,680,000
Income reported
82
Clients represented
434
Filings counted
0
Former members lobbying
Clients
top 50 of 82
- MEDICAL COUNTERMEASURES COALITION $940,000
- AMGEN INC. $480,000
- ELI LILLY AND COMPANY $480,000
- GILEAD SCIENCES, INC. $480,000
- JOHNSON & JOHNSON SERVICES, INC. $440,000
- GUARDANT HEALTH, INC. $400,000
- ILLUMINA, INC. $400,000
- PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA $400,000
- THE COALITION FOR 21ST CENTURY MEDICINE $380,000
- ALKERMES, INC. $360,000
- ALNYLAM PHARMACEUTICALS, INC. $360,000
- AMERICAN MEDICAL ASSOCIATION $360,000
- APOLLO GLOBAL MANAGEMENT $360,000
- GENENTECH, INC. $360,000
- GENMAB $360,000
- GLAXOSMITHKLINE LLC $360,000
- NOVARTIS, INC. $360,000
- NOVO NORDISK INC. $360,000
- PMI US CORPORATE SERVICES INC. $360,000
- ACTION NOW INITIATIVE, LLC $330,000
- BRISTOL-MYERS SQUIBB COMPANY $330,000
- ASTRAZENECA PHARMACEUTICALS LP $320,000
- COMPASS PATHWAYS INC. $320,000
- MYRIAD GENETICS, INC. $320,000
- PUERTO RICO DEPARTMENT OF HEALTH $320,000
- THE ORTHOFORUM $320,000
- ASTELLAS PHARMA US, INC. $300,000
- BAYER CORPORATION $300,000
- BIOGEN, INC. $300,000
- DELFI DIAGNOSTICS $300,000
- DH DIAGNOSTICS LLC $300,000
- EMD SERONO INC. $300,000
- EXELIXIS, INC. $300,000
- FOX CORPORATION $300,000
- MCKESSON CORPORATION $300,000
- NATIONAL EDUCATION ASSOCIATION $300,000
- OTSUKA AMERICA PHARMACEUTICAL, INC. $300,000
- SIDECAR HEALTH $300,000
- SIEMENS HEALTHINEERS $300,000
- TAKEDA PHARMACEUTICALS AMERICA, INC. $300,000
- U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTER $300,000
- KALDEROS, INC. $280,000
- MERCK & CO., INC. $280,000
- VANTIVE US HEALTHCARE LLC $280,000
- VAXART INC. $270,000
- VIAL HEALTH TECHNOLOGY, INC. $270,000
- INSULET CORPORATION $260,000
- PFIZER INC. $260,000
- NCTA - THE INTERNET & TELEVISION ASSOCIATION $250,000
- AMERICAN SOCIETY OF NEPHROLOGY $240,000
Lobbyists named
11
- PAUL EDATTEL
- DANIEL M TODD
- KATHERINE FLEMING COTTON
- ERIC BERGREN
- NICHOLAS UEHLECKE
- TED LEHMAN
- JEFF LUCAS
- TAYLOR SEXTON
- KIMBERLY LINTHICUM
- PETER LOUIS OPPENHEIM
- NICOLAS MAGALLANES
Reported by year
2 years
- 2026 $7,220,000
- 2025 $14,460,000
Issues lobbied
21
- Health Issues
- Medicare/Medicaid
- Pharmacy
- Education
- Budget/Appropriations
- Copyright/Patent/Trademark
- Taxation/Internal Revenue Code
- Trade (domestic/foreign)
- Telecommunications
- Government Issues
- Tariff (miscellaneous tariff bills)
- Tobacco
- Communications/Broadcasting/Radio/TV
- Financial Institutions/Investments/Securities
- Insurance
- Medical/Disease Research/Clinical Labs
- Economics/Economic Development
- Advertising
- Banking
- Labor Issues/Antitrust/Workplace
- Veterans
Agencies and chambers lobbied
8
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Centers For Medicare and Medicaid Services (CMS)
- Food & Drug Administration (FDA)
- White House Office
- Education, Dept of
- Office of Management & Budget (OMB)
Recent filings
454 total
Q2
MENARINI GROUP
Q2
VAXART INC.
Q2
VANTIVE US HEALTHCARE LLC
Q2
VALISURE
Q2
TAKEDA PHARMACEUTICALS AMERICA, INC.
Q2
SUNBOUND HOMES
Q2
SOUTHWEST TRANSPLANT ALLIANCE
Q2
SIDECAR HEALTH
Q2
PMI US CORPORATE SERVICES INC.
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Q2
PFIZER INC.
Q2
OTSUKA AMERICA PHARMACEUTICAL, INC.
Q2
NOVO NORDISK INC.
Q2
NOMI HEALTH, INC.
Q2
MYRIAD GENETICS, INC.
Q2
MUTUAL OF OMAHA
Q2
MILLIPORESIGMA
Q2
MERCK & CO., INC.
Q2
MEDICAL COUNTERMEASURES COALITION
Q2
MCKESSON CORPORATION